A detailed history of Kathleen S. Wright Associates Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 300 shares of EXAS stock, worth $17,820. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$17,820
Previous $12,000 66.67%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$41.33 - $74.26 $8,266 - $14,852
-200 Reduced 40.0%
300 $12,000
Q2 2023

Jul 20, 2023

BUY
$62.68 - $95.05 $31,340 - $47,525
500 New
500 $46,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Kathleen S. Wright Associates Inc. Portfolio

Follow Kathleen S. Wright Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathleen S. Wright Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kathleen S. Wright Associates Inc. with notifications on news.